APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dermatological Medicine Industry Research Report 2026

1 January 2026138 pages

Choose your research edition.

Industry ResearchDermatological Medicine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Medicine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Dermatological Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Medicine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Medicine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Dermatological Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dermatological Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dermatological Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dermatological Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dermatological Medicine include Chongqing Huapont Pharm Co., China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Johnson and Johnson, Merck, Harbin Letai, Pfizer, China Resources Pharmaceutical Group and Hebei Xinglong Xili Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dermatological Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dermatological Medicine Market by Company

Chongqing Huapont Pharm Co.

China National Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Johnson and Johnson

Merck

Harbin Letai

Pfizer

China Resources Pharmaceutical Group

Hebei Xinglong Xili Pharmaceutical

GSK

Bayer

AbbVie

Taisho Pharmaceutical

Reckitt Benckiser

Perrigo

LEO Pharma

Ikeda Mohando

DermaPharm A/S

Bright Future Pharmaceutical

Dermatological Medicine Segment by Type

Calcineurin Inhibitors

Anti-acne

Anti-infectives

Corticosteroids

Retinoids

Others

Dermatological Medicine Segment by Application

Psoriasis

Alopecia

Atopic Dermatitis

Herpes

Rosacea

Others

Dermatological Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dermatological Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dermatological Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dermatological Medicine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dermatological Medicine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Dermatological Medicine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dermatological Medicine Revenue of Manufacturers (2021-2026) Table 9. Global Dermatological Medicine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dermatological Medicine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Dermatological Medicine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dermatological Medicine, Product Type & Application Table 14. Global Dermatological Medicine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dermatological Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Huapont Pharm Co. Company Information Table 19. Chongqing Huapont Pharm Co. Business Overview Table 20. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio Table 22. Chongqing Huapont Pharm Co. Recent Developments Table 23. China National Pharmaceutical Group Company Information Table 24. China National Pharmaceutical Group Business Overview Table 25. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. China National Pharmaceutical Group Dermatological Medicine Product Portfolio Table 27. China National Pharmaceutical Group Recent Developments Table 28. Xiuzheng Pharmaceutical Group Company Information Table 29. Xiuzheng Pharmaceutical Group Business Overview Table 30. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio Table 32. Xiuzheng Pharmaceutical Group Recent Developments Table 33. Johnson and Johnson Company Information Table 34. Johnson and Johnson Business Overview Table 35. Johnson and Johnson Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Johnson and Johnson Dermatological Medicine Product Portfolio Table 37. Johnson and Johnson Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck Dermatological Medicine Product Portfolio Table 42. Merck Recent Developments Table 43. Harbin Letai Company Information Table 44. Harbin Letai Business Overview Table 45. Harbin Letai Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Harbin Letai Dermatological Medicine Product Portfolio Table 47. Harbin Letai Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Pfizer Dermatological Medicine Product Portfolio Table 52. Pfizer Recent Developments Table 53. China Resources Pharmaceutical Group Company Information Table 54. China Resources Pharmaceutical Group Business Overview Table 55. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio Table 57. China Resources Pharmaceutical Group Recent Developments Table 58. Hebei Xinglong Xili Pharmaceutical Company Information Table 59. Hebei Xinglong Xili Pharmaceutical Business Overview Table 60. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio Table 62. Hebei Xinglong Xili Pharmaceutical Recent Developments Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GSK Dermatological Medicine Product Portfolio Table 67. GSK Recent Developments Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Bayer Dermatological Medicine Product Portfolio Table 72. Bayer Recent Developments Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AbbVie Dermatological Medicine Product Portfolio Table 77. AbbVie Recent Developments Table 78. Taisho Pharmaceutical Company Information Table 79. Taisho Pharmaceutical Business Overview Table 80. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Taisho Pharmaceutical Dermatological Medicine Product Portfolio Table 82. Taisho Pharmaceutical Recent Developments Table 83. Reckitt Benckiser Company Information Table 84. Reckitt Benckiser Business Overview Table 85. Reckitt Benckiser Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Reckitt Benckiser Dermatological Medicine Product Portfolio Table 87. Reckitt Benckiser Recent Developments Table 88. Perrigo Company Information Table 89. Perrigo Business Overview Table 90. Perrigo Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Perrigo Dermatological Medicine Product Portfolio Table 92. Perrigo Recent Developments Table 93. LEO Pharma Company Information Table 94. LEO Pharma Business Overview Table 95. LEO Pharma Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. LEO Pharma Dermatological Medicine Product Portfolio Table 97. LEO Pharma Recent Developments Table 98. Ikeda Mohando Company Information Table 99. Ikeda Mohando Business Overview Table 100. Ikeda Mohando Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Ikeda Mohando Dermatological Medicine Product Portfolio Table 102. Ikeda Mohando Recent Developments Table 103. DermaPharm A/S Company Information Table 104. DermaPharm A/S Business Overview Table 105. DermaPharm A/S Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. DermaPharm A/S Dermatological Medicine Product Portfolio Table 107. DermaPharm A/S Recent Developments Table 108. Bright Future Pharmaceutical Company Information Table 109. Bright Future Pharmaceutical Business Overview Table 110. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bright Future Pharmaceutical Dermatological Medicine Product Portfolio Table 112. Bright Future Pharmaceutical Recent Developments Table 113. Global Dermatological Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Dermatological Medicine Sales by Region (2021-2026) & (K Units) Table 115. Global Dermatological Medicine Sales Market Share by Region (2021-2026) Table 116. Global Dermatological Medicine Sales by Region (2027-2032) & (K Units) Table 117. Global Dermatological Medicine Sales Market Share by Region (2027-2032) Table 118. Global Dermatological Medicine Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Dermatological Medicine Revenue Market Share by Region (2021-2026) Table 120. Global Dermatological Medicine Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Dermatological Medicine Revenue Market Share by Region (2027-2032) Table 122. North America Dermatological Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 124. North America Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 125. North America Dermatological Medicine Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Dermatological Medicine Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Dermatological Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 129. Europe Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 130. Europe Dermatological Medicine Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Dermatological Medicine Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Dermatological Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Dermatological Medicine Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Dermatological Medicine Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Dermatological Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 139. South America Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 140. South America Dermatological Medicine Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Dermatological Medicine Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Dermatological Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Dermatological Medicine Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Dermatological Medicine Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 148. Global Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 149. Global Dermatological Medicine Sales Market Share by Type (2021-2026) Table 150. Global Dermatological Medicine Sales Market Share by Type (2027-2032) Table 151. Global Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Dermatological Medicine Revenue Market Share by Type (2021-2026) Table 154. Global Dermatological Medicine Revenue Market Share by Type (2027-2032) Table 155. Global Dermatological Medicine Price by Type (2021-2026) & (US$/Unit) Table 156. Global Dermatological Medicine Price by Type (2027-2032) & (US$/Unit) Table 157. Global Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 158. Global Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 159. Global Dermatological Medicine Sales Market Share by Application (2021-2026) Table 160. Global Dermatological Medicine Sales Market Share by Application (2027-2032) Table 161. Global Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Dermatological Medicine Revenue Market Share by Application (2021-2026) Table 164. Global Dermatological Medicine Revenue Market Share by Application (2027-2032) Table 165. Global Dermatological Medicine Price by Application (2021-2026) & (US$/Unit) Table 166. Global Dermatological Medicine Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Dermatological Medicine Distributors List Table 170. Dermatological Medicine Customers List Table 171. Dermatological Medicine Industry Trends Table 172. Dermatological Medicine Industry Drivers Table 173. Dermatological Medicine Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dermatological Medicine Product Image Figure 5. Global Dermatological Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dermatological Medicine Market Size (2021-2032) & (US$ Million) Figure 7. Global Dermatological Medicine Sales (2021-2032) & (K Units) Figure 8. Global Dermatological Medicine Average Price (US$/Unit) & (2021-2032) Figure 9. Calcineurin Inhibitors Product Image Figure 10. Anti-acne Product Image Figure 11. Anti-infectives Product Image Figure 12. Corticosteroids Product Image Figure 13. Retinoids Product Image Figure 14. Others Product Image Figure 15. Psoriasis Product Image Figure 16. Alopecia Product Image Figure 17. Atopic Dermatitis Product Image Figure 18. Herpes Product Image Figure 19. Rosacea Product Image Figure 20. Others Product Image Figure 21. Global Dermatological Medicine Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Dermatological Medicine Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Dermatological Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Dermatological Medicine Sales by Region in 2025 Figure 27. Global Dermatological Medicine Revenue by Region in 2025 Figure 28. North America Dermatological Medicine Market Size by Country in 2025 Figure 29. North America Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 30. North America Dermatological Medicine Revenue Market Share by Country (2021-2032) Figure 31. United States Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Dermatological Medicine Market Size by Country in 2025 Figure 34. Europe Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 35. Europe Dermatological Medicine Revenue Market Share by Country (2021-2032) Figure 36. Germany Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Dermatological Medicine Market Size by Country in 2025 Figure 42. Asia Pacific Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Dermatological Medicine Revenue Market Share by Country (2021-2032) Figure 44. China Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. China Taiwan Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Dermatological Medicine Market Size by Country in 2025 Figure 53. South America Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 54. South America Dermatological Medicine Revenue Market Share by Country (2021-2032) Figure 55. Mexico Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Brazil Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Dermatological Medicine Market Size by Country in 2025 Figure 59. Middle East and Africa Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Dermatological Medicine Revenue Market Share by Country (2021-2032) Figure 61. Turkey Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. UAE Dermatological Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Dermatological Medicine Sales Market Share by Type (2021-2032) Figure 65. Global Dermatological Medicine Revenue Market Share by Type (2021-2032) Figure 66. Global Dermatological Medicine Price (US$/Unit) by Type (2021-2032) Figure 67. Global Dermatological Medicine Sales Market Share by Application (2021-2032) Figure 68. Global Dermatological Medicine Revenue Market Share by Application (2021-2032) Figure 69. Global Dermatological Medicine Price (US$/Unit) by Application (2021-2032) Figure 70. Dermatological Medicine Value Chain Figure 71. Dermatological Medicine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Dermatological Medicine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Calcineurin Inhibitors
  • Anti-acne
  • Anti-infectives
  • Corticosteroids
  • Retinoids
  • Others
Applications
  • Psoriasis
  • Alopecia
  • Atopic Dermatitis
  • Herpes
  • Rosacea
  • Others
Companies covered
  • Chongqing Huapont Pharm Co.
  • China National Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Johnson and Johnson
  • Merck
  • Harbin Letai
  • Pfizer
  • China Resources Pharmaceutical Group
  • Hebei Xinglong Xili Pharmaceutical
  • GSK
  • Bayer
  • AbbVie
  • Taisho Pharmaceutical
  • Reckitt Benckiser
  • Perrigo
  • LEO Pharma
  • Ikeda Mohando
  • DermaPharm A/S
  • Bright Future Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dermatological Medicine Market Size (2021-2032)
  4. 2.2.2 Global Dermatological Medicine Sales (2021-2032)
  5. 2.2.3 Global Dermatological Medicine Market Average Price (2021-2032)
  6. 2.3 Dermatological Medicine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Calcineurin Inhibitors
  9. 2.3.3 Anti-acne
  10. 2.3.4 Anti-infectives
  11. 2.3.5 Corticosteroids
  12. 2.3.6 Retinoids
  13. 2.3.7 Others
  14. 2.4 Dermatological Medicine by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Psoriasis
  17. 2.4.3 Alopecia
  18. 2.4.4 Atopic Dermatitis
  19. 2.4.5 Herpes
  20. 2.4.6 Rosacea
  21. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dermatological Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dermatological Medicine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Dermatological Medicine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dermatological Medicine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dermatological Medicine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dermatological Medicine, Product Type & Application
  8. 3.8 Global Manufacturers of Dermatological Medicine, Established Date
  9. 3.9 Global Dermatological Medicine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Huapont Pharm Co.
  2. 4.1.1 Chongqing Huapont Pharm Co. Company Information
  3. 4.1.2 Chongqing Huapont Pharm Co. Business Overview
  4. 4.1.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio
  6. 4.1.5 Chongqing Huapont Pharm Co. Recent Developments
  7. 4.2 China National Pharmaceutical Group
  8. 4.2.1 China National Pharmaceutical Group Company Information
  9. 4.2.2 China National Pharmaceutical Group Business Overview
  10. 4.2.3 China National Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 China National Pharmaceutical Group Dermatological Medicine Product Portfolio
  12. 4.2.5 China National Pharmaceutical Group Recent Developments
  13. 4.3 Xiuzheng Pharmaceutical Group
  14. 4.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 4.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 4.3.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio
  18. 4.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 4.4 Johnson and Johnson
  20. 4.4.1 Johnson and Johnson Company Information
  21. 4.4.2 Johnson and Johnson Business Overview
  22. 4.4.3 Johnson and Johnson Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Johnson and Johnson Dermatological Medicine Product Portfolio
  24. 4.4.5 Johnson and Johnson Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Dermatological Medicine Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 Harbin Letai
  32. 4.6.1 Harbin Letai Company Information
  33. 4.6.2 Harbin Letai Business Overview
  34. 4.6.3 Harbin Letai Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Harbin Letai Dermatological Medicine Product Portfolio
  36. 4.6.5 Harbin Letai Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Dermatological Medicine Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 China Resources Pharmaceutical Group
  44. 4.8.1 China Resources Pharmaceutical Group Company Information
  45. 4.8.2 China Resources Pharmaceutical Group Business Overview
  46. 4.8.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio
  48. 4.8.5 China Resources Pharmaceutical Group Recent Developments
  49. 4.9 Hebei Xinglong Xili Pharmaceutical
  50. 4.9.1 Hebei Xinglong Xili Pharmaceutical Company Information
  51. 4.9.2 Hebei Xinglong Xili Pharmaceutical Business Overview
  52. 4.9.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio
  54. 4.9.5 Hebei Xinglong Xili Pharmaceutical Recent Developments
  55. 4.10 GSK
  56. 4.10.1 GSK Company Information
  57. 4.10.2 GSK Business Overview
  58. 4.10.3 GSK Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 GSK Dermatological Medicine Product Portfolio
  60. 4.10.5 GSK Recent Developments
  61. 4.11 Bayer
  62. 4.11.1 Bayer Company Information
  63. 4.11.2 Bayer Business Overview
  64. 4.11.3 Bayer Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Bayer Dermatological Medicine Product Portfolio
  66. 4.11.5 Bayer Recent Developments
  67. 4.12 AbbVie
  68. 4.12.1 AbbVie Company Information
  69. 4.12.2 AbbVie Business Overview
  70. 4.12.3 AbbVie Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AbbVie Dermatological Medicine Product Portfolio
  72. 4.12.5 AbbVie Recent Developments
  73. 4.13 Taisho Pharmaceutical
  74. 4.13.1 Taisho Pharmaceutical Company Information
  75. 4.13.2 Taisho Pharmaceutical Business Overview
  76. 4.13.3 Taisho Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Taisho Pharmaceutical Dermatological Medicine Product Portfolio
  78. 4.13.5 Taisho Pharmaceutical Recent Developments
  79. 4.14 Reckitt Benckiser
  80. 4.14.1 Reckitt Benckiser Company Information
  81. 4.14.2 Reckitt Benckiser Business Overview
  82. 4.14.3 Reckitt Benckiser Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Reckitt Benckiser Dermatological Medicine Product Portfolio
  84. 4.14.5 Reckitt Benckiser Recent Developments
  85. 4.15 Perrigo
  86. 4.15.1 Perrigo Company Information
  87. 4.15.2 Perrigo Business Overview
  88. 4.15.3 Perrigo Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Perrigo Dermatological Medicine Product Portfolio
  90. 4.15.5 Perrigo Recent Developments
  91. 4.16 LEO Pharma
  92. 4.16.1 LEO Pharma Company Information
  93. 4.16.2 LEO Pharma Business Overview
  94. 4.16.3 LEO Pharma Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 LEO Pharma Dermatological Medicine Product Portfolio
  96. 4.16.5 LEO Pharma Recent Developments
  97. 4.17 Ikeda Mohando
  98. 4.17.1 Ikeda Mohando Company Information
  99. 4.17.2 Ikeda Mohando Business Overview
  100. 4.17.3 Ikeda Mohando Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Ikeda Mohando Dermatological Medicine Product Portfolio
  102. 4.17.5 Ikeda Mohando Recent Developments
  103. 4.18 DermaPharm A/S
  104. 4.18.1 DermaPharm A/S Company Information
  105. 4.18.2 DermaPharm A/S Business Overview
  106. 4.18.3 DermaPharm A/S Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 DermaPharm A/S Dermatological Medicine Product Portfolio
  108. 4.18.5 DermaPharm A/S Recent Developments
  109. 4.19 Bright Future Pharmaceutical
  110. 4.19.1 Bright Future Pharmaceutical Company Information
  111. 4.19.2 Bright Future Pharmaceutical Business Overview
  112. 4.19.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Bright Future Pharmaceutical Dermatological Medicine Product Portfolio
  114. 4.19.5 Bright Future Pharmaceutical Recent Developments
5 Global Dermatological Medicine Market Scenario by Region
  1. 5.1 Global Dermatological Medicine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dermatological Medicine Sales by Region: 2021-2032
  3. 5.2.1 Global Dermatological Medicine Sales by Region: 2021-2026
  4. 5.2.2 Global Dermatological Medicine Sales by Region: 2027-2032
  5. 5.3 Global Dermatological Medicine Revenue by Region: 2021-2032
  6. 5.3.1 Global Dermatological Medicine Revenue by Region: 2021-2026
  7. 5.3.2 Global Dermatological Medicine Revenue by Region: 2027-2032
  8. 5.4 North America Dermatological Medicine Market Facts & Figures by Country
  9. 5.4.1 North America Dermatological Medicine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dermatological Medicine Sales by Country (2021-2032)
  11. 5.4.3 North America Dermatological Medicine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Dermatological Medicine Market Facts & Figures by Country
  15. 5.5.1 Europe Dermatological Medicine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Dermatological Medicine Sales by Country (2021-2032)
  17. 5.5.3 Europe Dermatological Medicine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Dermatological Medicine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Dermatological Medicine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Dermatological Medicine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Dermatological Medicine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Dermatological Medicine Market Facts & Figures by Country
  35. 5.7.1 South America Dermatological Medicine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Dermatological Medicine Sales by Country (2021-2032)
  37. 5.7.3 South America Dermatological Medicine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Dermatological Medicine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Dermatological Medicine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Dermatological Medicine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Dermatological Medicine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Dermatological Medicine Sales by Type (2021-2032)
  2. 6.1.1 Global Dermatological Medicine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Dermatological Medicine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dermatological Medicine Revenue by Type (2021-2032)
  5. 6.2.1 Global Dermatological Medicine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dermatological Medicine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dermatological Medicine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dermatological Medicine Sales by Application (2021-2032)
  2. 7.1.1 Global Dermatological Medicine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Dermatological Medicine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dermatological Medicine Revenue by Application (2021-2032)
  5. 7.2.1 Global Dermatological Medicine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dermatological Medicine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dermatological Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dermatological Medicine Value Chain Analysis
  2. 8.1.1 Dermatological Medicine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dermatological Medicine Production Mode & Process
  5. 8.2 Dermatological Medicine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dermatological Medicine Distributors
  8. 8.2.3 Dermatological Medicine Customers
9 Global Dermatological Medicine Analyzing Market Dynamics
  1. 9.1 Dermatological Medicine Industry Trends
  2. 9.2 Dermatological Medicine Industry Drivers
  3. 9.3 Dermatological Medicine Industry Opportunities and Challenges
  4. 9.4 Dermatological Medicine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst